CONTENTS 目錄 MISSION STATEMENT 企業使命 We contribute to the advancement of society by providing people with quality products and employing advanced technology, with protecting the environment always in mind. We hire and nurture professionals and, together, we march towards our goals in pace with time. Putting customers first, we provide them with the best products and services, assuring win-win results. 創新科技 倡導環保 培育英才 共創理想 以客為本 互惠雙贏 CORPORATE OBJECTIVE 企業目標 To become a technologically advanced and innovative co ...

Financial Performance - Revenue for the six months ended September 30, 2025, was HKD 228,330,000, a decrease of 26.5% compared to HKD 310,905,000 for the same period in 2024[6] - Gross profit for the same period was HKD 13,563,000, down 47.5% from HKD 25,782,000 in 2024[6] - Operating loss for the six months was HKD 10,123,000, compared to an operating profit of HKD 1,577,000 in the previous year[6] - The company reported a loss attributable to owners of HKD 11,523,000 for the six months, compared to a profit of HKD 70,000 in the same period last year[6] - Revenue for air freight forwarding services decreased to HKD 121,768,000, down 42.5% from HKD 212,082,000 in the previous year[19] - Revenue from air cargo station operation services increased to HKD 106,562,000, up 7.0% from HKD 98,823,000 in the previous year[19] - Total revenue for the six months ended September 30, 2025, was HKD 228,330,000, a decrease of 26.5% compared to HKD 310,905,000 in the same period last year[19] - The company reported a loss attributable to shareholders of HKD 11,523,000 for the six months ended September 30, 2025, compared to a profit of HKD 70,000 for the same period in 2024, resulting in a basic loss per share of HKD (0.12) compared to HKD 0.01 in the previous year[34] Cash Flow and Financing - The net cash used in financing activities was HKD 21,255,000, an improvement from HKD 28,438,000 in the prior year[12] - Cash and cash equivalents at the end of the period were HKD 58,428,000, down from HKD 79,225,000 at the beginning of the period[12] - The company reported no bank borrowing interest for the current period, compared to HKD 26,000 in the previous year[28] - The company has incurred operational funding of approximately HKD 0.2 million for initial operations during the review period[85] Assets and Liabilities - Total assets decreased to HKD 281,620,000 as of September 30, 2025, from HKD 319,981,000 as of March 31, 2025[8] - The company's equity attributable to owners decreased to HKD 172,801,000 from HKD 184,324,000[8] - Trade receivables increased to HKD 119,576,000 from HKD 116,533,000[8] - Trade payables were reported at HKD 21,566,000 as of September 30, 2025, compared to HKD 24,661,000 as of March 31, 2025[46] - The company's current assets net value was approximately HKD 121.1 million as of September 30, 2025, down from approximately HKD 132.6 million as of March 31, 2025[66] - The debt-to-equity ratio was approximately 30.0% as of September 30, 2025, down from 38.8% as of March 31, 2025, primarily due to a reduction in lease liabilities[68] Operational Highlights - Direct labor costs were HKD 51,393,000, down 17.2% from HKD 62,021,000 in the previous year[26] - Total administrative and other operating expenses included property, plant, and equipment depreciation of HKD 3,055,000, up from HKD 640,000 in the previous year[26] - The company maintained stable administrative and operating expenses at approximately HKD 25.4 million for the review period[61] - The financial costs remained stable at approximately HKD 1.5 million for both the review period and the previous period[63] - As of September 30, 2025, the group employed 324 staff, a decrease from 363 staff as of March 31, 2025, with total employee costs amounting to approximately HKD 59.2 million[71] Strategic Initiatives - The company is cautiously optimistic about the medium to long-term development of the industry, anticipating a gradual recovery in international logistics demand[57] - The company plans to diversify its business model, including value-added services and integrated logistics solutions, to enhance revenue sources and profitability[57] - The group has established a new warehouse property of approximately 130,000 square feet in Tuen Mun, with ongoing renovations and installations of security systems[80] - The group has purchased an additional 13 units of 16-ton trucks and one unit of 5.5-ton truck, enhancing its logistics capabilities[82] - The warehouse management system has been upgraded to improve data accuracy and transparency in freight operations[83] Corporate Governance - The company has adhered to the corporate governance code during the review period and up to the report date[111] - The Audit Committee, established on February 21, 2018, includes independent non-executive directors and is responsible for reviewing financial information and overseeing the financial reporting system[112] - The interim financial statements for the review period were not audited but were reviewed by the Audit Committee, which found them compliant with applicable accounting standards and listing rules[112] - The board of directors includes both executive and independent non-executive members, ensuring a diverse governance structure[115] Shareholder Information - The company has a significant shareholder structure, with Mr. Luo Guoliang and Mr. Luo Guohao each holding 75% of the company's shares through Dynamic Victor, totaling 750 million shares[90][91] - Dynamic Victor, as a beneficial owner, holds 75% of the company's shares, equivalent to 750 million shares[94] - Zhao Datting sold 10% of Dynamic Victor's shares, resulting in ownership of 65% and 35% for Luo Guoliang and Luo Guohao respectively[99] - The company has a stock option plan with a maximum issuance limit of 100,000,000 shares, representing 10% of all issued shares at the time of listing[103] - The stock option plan aims to attract and retain top talent, providing additional incentives to employees, directors, and business partners[102]

Financial Performance - Revenue for the six months ended 30 September 2025 was approximately HK$270.9 million, representing a decrease of approximately 5% compared to the corresponding period in 2024[9]. - Gross profit for the same period was approximately HK$42.4 million, reflecting a decrease of approximately 16% compared to the prior year[9]. - The loss attributable to owners of the Company for the period was approximately HK$29.3 million, an increase of approximately 537% compared to the same period in 2024[9]. - Loss per share for the period was HK Cents 2.6, compared to HK Cents 0.40 in 2024[9]. - Total comprehensive loss for the period was approximately HK$28,402,000, compared to a loss of HK$3,699,000 in the previous period[18]. - The Group reported a total comprehensive expense for the period of approximately HK$29.2 million, compared to HK$3.68 million in 2024[13]. - The Group's reportable segment loss for the six months ended September 30, 2025, was HK$27,589,000, compared to a profit of HK$4,000 in the same period of 2024[45]. Revenue Breakdown - Revenue from property management and related services was HK$270,908,000, down from HK$284,369,000, reflecting a decline of 4.7%[32]. - Revenue from Hong Kong was HK$265,171,000, a decrease of 3.7% compared to HK$275,361,000 in 2024[33]. - Revenue from the People's Republic of China (PRC) dropped to HK$5,737,000, down 36.5% from HK$9,008,000 in the previous year[33]. - Revenue from property management services contracts decreased by approximately 3.8% to approximately HK$243.7 million for the six months ended 30 September 2025[86]. - Revenue from stand-alone security services contracts was approximately HK$27.2 million for the six months ended 30 September 2025, representing approximately 10.0% of total revenue[81]. - The group did not report any rental income from investment properties during the period, compared to HK$802,000 in 2024[32]. Expenses and Costs - Administrative expenses increased to approximately HK$59.6 million, up from HK$39.9 million in the corresponding period of 2024[12]. - Loss from operations for the period was approximately HK$30.5 million, compared to a loss of HK$3.97 million in the same period last year[12]. - Other operating expenses decreased by approximately 8.8% to HK$14.5 million for the six months ended 30 September 2025, compared to HK$15.9 million in 2024[92][95]. - Staff costs for the six months ended September 30, 2025, amounted to HK$231,647,000, an increase from HK$227,747,000 in the same period of 2024[49]. - Depreciation of property, plant, and equipment for the six months ended September 30, 2025, was HK$7,037,000, compared to HK$5,895,000 in the same period of 2024[49]. Assets and Liabilities - As of September 30, 2025, total assets less current liabilities amounted to HK$170,154,000, a decrease from HK$197,941,000 as of March 31, 2025, representing a decline of approximately 14%[15]. - Net current assets decreased to HK$66,875,000 from HK$97,720,000, indicating a reduction of about 32%[15]. - Total assets as of September 30, 2025, were HK$240,363,000, down from HK$270,731,000 as of March 31, 2025[45]. - Total liabilities as of September 30, 2025, were HK$72,500,000, a slight decrease from HK$73,661,000 as of March 31, 2025[45]. - Current liabilities decreased slightly to HK$70,209,000 from HK$72,790,000, a reduction of about 4%[15]. Cash Flow and Financing - The net cash generated from operating activities for the six months ended September 30, 2025, was HK$15,429,000, a significant improvement compared to a cash outflow of HK$6,803,000 in the same period of 2024[20]. - Cash and cash equivalents at the end of the period increased to HK$38,596,000 from HK$30,764,000, reflecting a rise of approximately 25%[20]. - The group’s total debt, including bank and other loans and lease liabilities, was approximately HK$4 million as of September 30, 2025, down from HK$5.8 million as of March 31, 2025[114]. - The group’s gearing ratio as of September 30, 2025, was approximately 2.4%, a decrease from 2.9% as of March 31, 2025[125]. Corporate Governance - The company has complied with all Corporate Governance Code provisions except for the separation of roles between the chairman and chief executive, which has not been established since there has been no CEO since September 8, 2015[143][144][147]. - The board emphasizes its commitment to strengthening the governance framework and ensuring compliance with GEM Listing Rules in all transactions and disclosures[151]. - The company acknowledges the importance of strict adherence to GEM Listing Rules and regrets the oversights that led to delays in disclosure[149][154]. - The board believes that the current arrangement without a CEO is adequate for effective management and control of the company's operations[144][146]. Share Award Plan - The Share Award Plan was adopted on August 6, 2021, to recognize and reward contributions from eligible participants[169]. - The total maximum number of shares that may be awarded under the Share Award Plan is capped at 10% of the shares in issue, which amounts to 102,635,151 shares based on 1,026,351,515 shares in issue at the adoption date[182]. - For the six months ended 30 September 2025, there were no Awards granted under the Plan, and no Awards were vested, cancelled, or lapsed during this period[198]. - The Share Award Plan aims to attract suitable personnel for the Group's development and retain existing employees[170].

Financial Performance - Revenue for the six months ended September 30, 2025, was HK$1,618,471,000, a decrease of 10.1% from HK$1,800,461,000 in the same period of 2024[4] - Gross profit for the same period was HK$487,638,000, down 13.0% from HK$560,423,000 year-over-year[4] - Profit for the period attributable to owners of the Company was HK$100,782,000, a decline of 15.6% compared to HK$119,398,000 in 2024[5] - Basic earnings per share decreased to 20.68 HK cents from 24.50 HK cents, reflecting a 15.4% drop[5] - Total comprehensive income for the period was HK$124,955,000, down 15.7% from HK$148,307,000 in the previous year[5] Cash and Assets - Cash and cash equivalents increased to HK$978,785,000 from HK$836,081,000, representing a growth of 17.0%[6] - Non-current assets totaled HK$636,452,000, an increase from HK$589,431,000 as of March 31, 2025[6] - Current liabilities rose to HK$464,386,000 from HK$346,991,000, indicating a significant increase of 33.8%[6] - Inventories decreased to HK$446,427,000 from HK$466,304,000, a reduction of 4.0%[6] - As of September 30, 2025, net current assets increased to HK$1,327,301, up from HK$1,307,091 as of March 31, 2025, reflecting a growth of approximately 1.6%[7] Equity and Dividends - Total equity reached HK$1,798,348, up from HK$1,754,782, representing an increase of approximately 2.5%[7] - The company declared a final dividend of HK$20,469,000 and a special dividend of HK$60,920,000 for the fiscal year 2025[8] - The company proposed an interim dividend of HK$25,830,000 and an interim special dividend of HK$75,541,000 for the fiscal year 2026[8] - The total equity attributable to owners of the company increased to HK$1,796,537,000 as of September 30, 2025, compared to HK$1,753,039,000 at the beginning of the period[8] Segment Performance - Segment revenue for Hong Kong decreased to HK$351,481,000 in 2025 from HK$423,882,000 in 2024, a decline of approximately 17%[28] - Segment revenue for The PRC was HK$1,261,103,000 in 2025, down from HK$1,322,763,000 in 2024, representing a decrease of about 5%[28] - Segment profit for The PRC increased to HK$218,149,000 in 2025 from HK$212,328,000 in 2024, a growth of approximately 3.7%[28] Operational Insights - The luxury sector has faced increasing pressure due to a shift in consumer spending towards experiences, travel, and wellness[137] - The Group's performance has been affected by cautious consumer spending patterns prioritizing daily necessities over luxury goods[137] - Watch exports to Chinese Mainland and Hong Kong declined by 16.3% and 8.3%, respectively, between January and September 2025[149] Employee and Governance - The Group had no bank loans as of September 30, 2025, resulting in a nil gearing ratio[151] - Approximately 64% of the Group's 570 employees were located in Chinese Mainland as of September 30, 2025[157] - The Company has adhered to the Corporate Governance Code throughout the reporting period, with a noted deviation regarding the separation of the roles of chairman and chief executive[165] Share Award Scheme - The group has a share award scheme valid for 10 years, aimed at motivating and retaining eligible employees and directors[90] - The total number of awards available for grant under the 2022 Share Award Scheme is 48,735,822 shares, representing 10% of the issued share capital of the Company as of the report date[94] - No share award has been granted under the 2022 Share Award Scheme since the Adoption Date[94]

目錄 2 簡明綜合損益及其他全面收益表 3 簡明綜合財務狀況表 5 簡明綜合權益變動表 6 簡明綜合現金流量表 7 簡明綜合財務報表附註 17 管理層討論及分析 21 其他資料 簡明綜合損益及其他全面收益表 截至2025年9月30日止六個月 （以港元列示） | | | 截至9月30日止六個月 | | | --- | --- | --- | --- | | | | 2025年 | 2024年 | | | 附註 | 千港元 | 千港元 | | | | （未經審核） | （未經審核） | | 收益 | 4 | 45,045 | 44,622 | | 銷售成本 | 5 | (24,754) | (24,234) | | 毛利 | | 20,291 | 20,388 | | 其他收入 | | 5 | 56 | | 分階段收購一間附屬公司之收益 | 11 | – | 1,499 | | 銷售及分銷開支 | 5 | (8,798) | (7,136) | | 行政開支 | 5 | (10,334) | (10,908) | | 經營溢利 | | 1,164 | 3,899 | | 財務收入 | | 387 | 687 | ...

香港聯合交易所有限公司（「聯交所」）GEM的特色 GEM的定位，乃為中小型公司提供一個上市的市場，此等公司相比起其他在聯交所上市的公司帶有較高 投資風險。有意投資的人士應了解投資於該等公司的潛在風險，並應經過審慎周詳的考慮後方作出投資決 定。 由於GEM上市公司普遍為中小型公司，在GEM買賣的證券可能會較於主板買賣之證券承受較大的市場波 動風險，同時無法保證在GEM買賣的證券會有高流通量的市場。 香港交易及結算所有限公司及聯交所對本報告的內容概不負責，對其準確性或完整性亦不發表任何聲明， 並明確表示概不就因本報告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 本報告包括的資料乃遵照聯交所的GEM證券上市規則（「GEM上市規則」）的規定而提供有關源想集團有限 公司（「本公司」）及其附屬公司（統稱「本集團」）的資料。本公司董事（「董事」）願就本報告共同及個別承擔 全部責任。董事在作出一切合理查詢後確認，就彼等所知及所信，本報告所載資料在各重大方面均屬準確 完整，且無誤導或欺騙成份，及本報告並無遺漏其他事項，致使本報告或當中所載任何陳述產生誤導。 1 源想集團有限公司 • 2025年中期報告 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致之任何損失承擔任何責任。 GUANGDONG – HONG KONG GREATER BAY AREA HOLDINGS LIMITED 除2014年年報所載資料外，本公司董事（「董事」）會（「董事會」）謹此提供以下補 充資料。 根據上市規則附錄D2第24段（或當時上市規則附錄16），本公司謹此提供有關本 公司前任行政總裁王德文先生（「王先生」）截至2014年12月31日止年度薪酬的補 充資料。王德文先生於2014年5月13日獲委任為本公司行政總裁，於2015年1月 26日獲委任為本公司執行董事，並已於2022年辭任行政總裁及執行董事。 1 據董事作出一切合理查詢後所知、所悉及所信，王先生於截至2014年12月31日止 年度的薪酬如下： 以權益結算 薪金、津貼 退休計劃 以股份為基 粵港灣控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：1396） 與截至2014年12月31日止年度的年度報告有關的補充公告 茲提述粵港 ...

Love The Community Serve The Better 服務美好 、善愛生活 Annual Report 2024 年報 Annual Report 2024 年報 OPERATION is the Key REPUTATION Comes First Service provider for the community and industry 社區運營服務商、產業運營服務商 BUSINESS MOTTO 經營理念 Surpassing Customers' Expectation and Creating Values with Quality Services 超越客戶期待、 服務創造價值 Leading Property Management Enterprise in the Yangtze River Delta Megalopolis 運營為王 口碑至上 長三角領先物管企業 BUSINESS MODEL 業務模式 Service alignment, Business modularisation, Modules specialisation and Management di ...

Serve The Better Love The Community 服務美好 、善愛生活 Interim Report 2024 中期報告 Interim Report 2024 中期報告 CONTENT 目錄 | 2 | Company Introduction | 28 | Interim Condensed Consolidated Statement | | --- | --- | --- | --- | | | 公司簡介 | | of Profit or Loss and Other Comprehensive Income | | | | | 中期簡明綜合損益及其他全面收益表 | | 3 | Corporate Information | | | | | 公司資料 | 30 | Interim Condensed Consolidated Statement of | | | | | Financial Position | | 5 | Management Discussion and Analysis | | 中期簡明綜合財務狀況表 | | | 管理層討論與分析 | | | | | | 3 ...

Revenue Performance - Medical products revenue for the fiscal year 2024 reached HKD 25.57 million, a 16.5% increase from HKD 21.94 million in fiscal year 2023[5] - Custom components for medical equipment saw a significant revenue increase of 86%, driven by a shift towards comprehensive systems like Continuous Glucose Monitoring (CGM)[8] - Sales of blood collection tubes and equipment dropped from HKD 30.43 million in fiscal year 2022 to HKD 14.13 million in fiscal year 2023, a decline of 53.6%[7] - Revenue from pandemic-related products fell to zero in fiscal year 2023, a 100% decrease from HKD 16.34 million in fiscal year 2022, due to normalized demand post-COVID-19[6] Product Development and Expansion - The company plans to expand its product offerings to include surgical instruments, orthopedic tools, imaging equipment, and disinfection products[11] - The company intends to launch 2 to 3 new co-developed products by 2026, including surgical instrument kits and imaging equipment accessories[14] - The newly obtained production license is a strategic expansion of the existing medical business segment, significantly broadening the product portfolio with new devices and components, including infusion and transfusion devices, nursing and care equipment, and protective gear[15] - The production license allows the company to market and sell a diverse range of medical devices in China, covering categories such as active and passive surgical instruments, orthopedic surgical instruments, medical imaging equipment, and more[16] Regulatory Compliance and Quality Control - The company is focusing on diversifying its product lines while ensuring regulatory compliance with certifications like CE and FDA[11] - The company emphasizes compliance with strict quality and regulatory standards to ensure the highest levels of safety and effectiveness for its medical products[28] - The production facilities have received FDA certification, reflecting the company's commitment to adhering to strict regulatory frameworks[28] - The company emphasizes strict quality control and regulatory compliance in all operations, whether internal or outsourced[30] Market Strategy and Partnerships - The company aims to achieve product registration and distribution permits in Shandong by August 2025, marking a significant milestone for market entry[12] - The company is actively seeking partnerships with subcontractors that have existing certifications to expedite market entry without significant capital expenditure[12] - The company anticipates obtaining additional provincial registrations in China by the fourth quarter of 2026 to expand its geographical coverage[13] - The company will adopt a data-driven regional expansion strategy to optimize service delivery and enhance commitment to hospital clients[34] Operational Capacity and Team - The company has established an 8-member dedicated operations team led by Mr. Dai Zhongliang, who has over ten years of experience in the medical products industry, to manage and monitor all manufacturing processes[27] - The company has a maximum annual production capacity of approximately 5 million units at its existing facility in Dongguan, China[31] - The business model under the production license remains unchanged, ensuring rapid expansion of the product range while maintaining effective operational strategies[17] Financial Projections and Market Outlook - The Chinese healthcare market is projected to grow at a compound annual growth rate of approximately 12-14%, reaching over $250 billion by 2030[32] - The company plans to achieve estimated sales of RMB 20 million by December 2025 through strategic partnerships with clients introduced by a new management team member[33] - The board is optimistic about business prospects due to strong market demand and strategic initiatives taken[32] - The establishment of a new subsidiary in Jinan, Shandong, aims to strengthen the company's market presence in China[33] Customer Engagement and Sales Strategy - The sales and marketing department is tasked with customer engagement, handling inquiries, and coordinating sales orders to ensure timely processing and delivery[23] - The company aims to enhance its core business by providing a more comprehensive product suite to meet broader customer needs and generate additional revenue streams[15] - The company will expand its customer base to include hospital clients, diversifying revenue sources and strengthening market position[33]